Which painkiller wins after hernia surgery? new trial tests BDE vs exparel

NCT ID NCT07518238

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial compares two numbing medications—BDE (a mix of bupivacaine, dexamethasone, and epinephrine) and Exparel—to see which one reduces pain better after hernia surgery. About 128 adults having abdominal wall reconstruction will receive one of the drugs during a nerve block. Researchers will measure pain levels, how much extra pain medication is needed, and how long patients stay in the hospital.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bupivacaine, Dexamethasone, Epinephrine (BDE) and Exparel (liposomal bupivacaine)
What this could lead to
If this works, it could show which numbing medication provides better pain relief and faster recovery after hernia surgery.
What could go wrong
This is a small, early-phase trial with only 128 participants, so results may not apply to everyone. The study is still enrolling, and it's unclear if one drug is clearly better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BDE FOR HERNIA PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor University Medical Center

    Dallas, Texas, 75246, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.